Evidence map›Paper›PMID 33865337›Full record

ArticleBMC neurology2021

German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis.

Barbara Seebacher, Roger J Mills, Markus Reindl, Laura Zamarian, Simone Kircher, Christian Brenneis, Rainer Ehling, Florian Deisenhammer

Registry-linked trialOpen access · goldAbstract readValidation Study
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06231030 (Adaptation, Validity and Reliability of "Unidimensional Self-Efficacy Scale for Multiple Sclerosis), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06231030 unknown statusnot on this mapstarted 2023, after this paper: background citation

Adaptation, Validity and Reliability of "Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS)" in Turkish

Typeobservational_patient_registrySponsorNigde Omer Halisdemir UniversityRan2023 to 2025Enrolled120ConditionsMultiple Sclerosis, Self EfficacyArmsValidity, Reliability and Adaptation
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Barbara SeebacherClinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. barbara.seebacher@i-med.ac.at.ORCID http://orcid.org/0000-0001-5699-9077
Roger J MillsDepartment of Neurology, Walton Centre NHS Foundation Trust, Liverpool, UK.
Markus ReindlClinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Laura ZamarianClinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Simone KircherClinical Department of Neurology, University Hospital of Innsbruck, Innsbruck, Austria.
Christian BrenneisDepartment of Neurology, Clinic for Rehabilitation Münster, Münster, Austria.
Rainer EhlingDepartment of Neurology, Clinic for Rehabilitation Münster, Münster, Austria.
Florian DeisenhammerClinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Innsbruck Medical University · ATKarl Landsteiner Society · ATUniversity Hospital Innsbruck · ATUniversity of Liverpool · GB

Funding

Austrian Multiple Sclerosis Research Society No grant number
6 · The paper itself

Abstract

backgroundSelf-efficacy concerns individuals' beliefs in their capability to exercise control in specific situations and complete tasks successfully. In people with multiple sclerosis (PwMS), self-efficacy has been associated with physical activity levels and quality of life. As a validated German language self-efficacy scale for PwMS is missing the aims of this study were to translate the Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) into German, establish face and content validity and cultural adaptation of the German version for PwMS in Austria. A further aim was to validate the German USE-MS (USE-MS-G) in PwMS.

methodsPermission to translate and validate the USE-MS was received from the scale developers. Following guidelines for translation and validation of questionnaires and applying Bandura's concept of self-efficacy, the USE-MS was forward-backward translated with content and face validity established. Cultural adaptation for Austria was performed using cognitive patient interviews. Reliability was assessed using Cronbach's alpha, Person separation index and Lin's concordance correlation coefficient. Rasch analysis was employed to assess construct validity. Comparison was made to scales for resilience, general self-efficacy, anxiety and depression, multiple sclerosis fatigue and health-related quality of life. Data were also pooled with an historic English dataset to compare the English and German language versions.

resultsThe translation and cultural adaptation were successfully performed in the adaptation process of the USE-MS-G. Pretesting was conducted in 30 PwMS, the validation of the final USE-MS-G involved 309 PwMS with minimal to severe disability. The USE-MS-G was found to be valid against the Rasch model when fitting scale data using a bifactor solution of two super-items. It was shown to be unidimensional, free from differential item functioning and well targeted to the study population. Excellent convergent and known-groups validity, internal consistency, person separation reliability and test-retest reliability were shown for the USE-MS-G. Pooling of the English and German datasets confirmed invariance of item difficulties between languages.

conclusionThe USE-MS-G is a robust, valid and reliable scale to assess self-efficacy in PwMS and can generate interval level data on an equivalent metric to the UK version.

trial registrationISRCTN Registry; ISRCTN14843579 ; prospectively registered on 02. 01. 2019.

Indexed as

Self EfficacySurveys and QuestionnairesTranslationsAdultAustriaFemaleHumansLanguageMaleMiddle AgedMultiple SclerosisPsychometricsQuality of LifeReproducibility of ResultsTranslatingAustriaCross-cultural comparisonMultiple sclerosisPatient reported outcome measuresSelf-efficacyValidation studies

Identifiers

PMID33865337
PMCPMC8052731
OpenAlexW3156823531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.